Tsc2 null murine neuroepithelial cells are a model for human tuber giant cells, and show activation of an mTOR pathway

Molecular and Cellular Neuroscience

Volumn 21, Issue 4, 2002, Pages 561-574

  Onda, Hiroaki ^a   Crino, Peter B ^b   Zhang, Hongbing ^a   Murphey, Ryan D ^c   Rastelli, Luca ^c   Rothberg, Bonnie E Gould ^c   Kwiatkowski, David J ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c CURAGEN CORPORATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA TUBULIN; GROWTH FACTOR; RAPAMYCIN; S6 KINASE; STAT3 PROTEIN;

ANIMAL CELL; ARTICLE; AUTISM; BRAIN MALFORMATION; CONTROLLED STUDY; EPILEPSY; GIANT CELL; HUMAN; HUMAN CELL; MORPHOLOGY; NEUROEPITHELIUM; NONHUMAN; NUCLEOTIDE SEQUENCE; PATHOGENESIS; PRIORITY JOURNAL; STEM CELL; TUBER (GENUS); TUBEROUS SCLEROSIS; UNINDEXED SEQUENCE;

ANIMALIA; MURINAE;

EID: 0036943576     PISSN: 10447431     EISSN: None     Source Type: Journal    
DOI: 10.1006/mcne.2002.1184     Document Type: Article

References (55)

1. Alessi, D. R., Kozlowski, M. T., Weng, Q. P., Morrice, N., and Avruch, J. (1998). 3-Phosphoinositide-dependent protein kinase 1 (PDK1) phosphorylates and activates the p70 S6 kinase in vivo and in vitro. Curr. Biol. 8: 69-81.
2. Arai, Y., Ackerley, C. A., and Becker, L. E. (1999). Loss of the TSC2 product tuberin in subependymal giant-cell tumors. Acta Neuropathol. (Berl) 98: 233-239.
3. Au, K. S., Hebert, A. A., Roach, E. S., and Northrup, H. (1999). Complete inactivation of the TSC2 gene leads to formation of hamartomas. Am. J. Hum. Genet. 65: 1790-1795.
4. Belham, C., Comb, M. J., and Avruch, J. (2001). Identification of the NIMA family kinases NEK6/7 as regulators of the p70 ribosomal S6 kinase. Curr. Biol. 11: 1155-1167.
5. Bolton, P. F., and Griffiths, P. D. (1997). Association of tuberous sclerosis of temporal lobes with autism and atypical autism. Lancet 349: 392-395.
6. Brunn, G. J., Hudson, C. C., Sekulic, A., Williams, J. M., Hosoi, H., Houghton, P. J., Lawrence, J. C., Jr. et al. (1997). Phosphorylation of the translational repressor PHAS-I by the mammalian target of rapamycin. Science 277: 99-101.
7. Burnett, P. E., Barrow, R. K., Cohen, N. A., Snyder, S. H., and Sabatini, D. M. (1998). RAFT1 phosphorylation of the translational regulators p70 S6 kinase and 4E-BP1. Proc. Natl. Acad. Sci. USA 95: 1432-1437.
8. Carbonara, C., Longa, L., Grosso, E., Mazzucco, G., Borrone, C., Garre, M. L., Brisigotti, M. et al. (1996). Apparent preferential loss of heterozygosity at TSC2 over TSC1 chromosomal region in tuberous sclerosis hamartomas. Genes Chromosomes Cancer 15: 18-25.
9. Cheadle, J. P., Reeve, M. P., Sampson, J. R., and Kwiatkowski, D. J. (2000). Molecular genetic advances in tuberous sclerosis. Hum. Genet. 107: 97-114.
10. Consortium. The European Chromosome 16 Tuberous Sclerosis (1993). Identification and characterization of the tuberous sclerosis gene on chromosome 16. Cell 75: 1305-1315.
11. Crino, P. B., and Henske, E. P. (1999). New developments in the neurobiology of the tuberous sclerosis complex. Neurology 53: 1384-1390.
12. Crino, P. B., Trojanowski, J. Q., Dichter, M. A., and Eberwine, J. (1996). Embryonic neuronal markers in tuberous sclerosis: Single-cell molecular pathology. Proc. Natl. Acad. Sci. USA 93: 14152-14157.
13. Curatolo, P., Seri, S., Verdecchia, M., and Bombardieri, R. (2001). Infantile spasms in tuberous sclerosis complex. Brain Dev. 23: 502-507.
14. Dabora, S. L., Jozwiak, S., Franz, D. N., Roberts, P. S., Nieto, A., Chung, J., Choy, Y. S. et al. (2001). Mutational analysis in a cohort of 224 tuberous sclerosis patients indicates increased severity of TSC2, compared with TSC1, disease in multiple organs. Am. J. Hum. Genet. 68: 64-80.
15. Ewalt, D. H., Sheffield, E., Sparagana, S. P., Delgado, M. R., and Roach, E. S. (1998). Renal lesion growth in children with tuberous sclerosis complex. J. Urol. 160: 141-145.
16. Franz, D. N., Tudor, C., Leonard, J., Egelhoff, J. C., Byars, A., Valerius, K., and Sethuraman, G. (2001). Lamotrigine therapy of epilepsy in tuberous sclerosis. Epilepsia 42: 935-940.
17. Gao, X., and Pan, D. (2001). TSC1 and TSC2 tumor suppressors antagonize insulin signaling in cell growth. Genes Dev. 15: 1383-1392.
18. Gingras, A. C., Gygi, S. P., Raught, B., Polakiewicz, R. D., Abraham, R. T., Hoekstra, M. F., Aebersold, R. et al. (1999). Regulation of 4E-BP1 phosphorylation: A novel two-step mechanism. Genes Dev. 13: 1422-1437.
19. Gomez, M., Sampson, J., and Whittemore, V. (1999). In "The Tuberous Sclerosis complex." Oxford Univeristy Press, Oxford, England.
20. Green, A. J., Smith, M., and Yates, J. R. (1994). Loss of heterozygosity on chromosome 16p 13.3 in hamartomas from tuberous sclerosis patients. Nat. Genet. 6: 193-196.
21. Gutierrez, G. C., Smalley, S. L., and Tanguay, P. E. (1998). Autism in tuberous sclerosis complex. J. Autism Dev. Disord. 28: 97-103.
22. Henske, E. P., Scheithauer, B. W., Short, M. P., Wollmann, R., Nahmias, J., Hornigold, N., van Slegtenhorst, M. et al. (1996). Allelic loss is frequent in tuberous sclerosis kidney lesions but rare in brain lesions. Am. J. Hum. Genet. 59: 400-406.
23. Henske, E. P., Wessner, L. L., Golden, J., Scheithauer, B. W., Vortmeyer, A. O., Zhang, Z., Klein-Szanto, A. J. P. et al. (1997). Loss of tuberin in both subependymal giant cell astrocytomas and angiomyolipomas supports a two-hit model for the pathogenesis of tuberous sclerosis tumors. Am. J. Path. 151: 1639 -1647.
24. Hunt, A., and Shepherd, C. (1993). A prevalence study of autism in tuberous sclerosis. J. Autism Dev. Disord. 23: 323-339.
25. Johnson, M. W., Emelin, J. K., Park, S. H., and Vinters, H. V. (1999). Co-localization of TSC1 and TSC2 gene products in tubers of patients with tuberous sclerosis. Brain Pathol. 9: 45-54.
26. Jones, A. C., Shyamsundar, M. M., Thomas, M. W., Maynard, J., Idziaszczyk, S., Tomkins, S., Sampson, J. R. et al. (1999). Comprehensive mutation analysis of TSC1 and TSC2-and phenotypic correlations in 150 families with tuberous sclerosis. Am. J. Hum. Genet. 64: 1305-1315.
27. Jozwiak, S., Schwartz, R. A., Janniger, C. K., and Bielicka-Cymerman, J. (2000). Usefulness of diagnostic criteria of tuberous sclerosis complex in pediatric patients. J. Child Neurol. 15: 652-659.
28. Kwiatkowski, D. J., and Short, M. P. (1994). Tuberous sclerosis. Arch. Derm. 130: 348-354.
29. Kwiatkowski, D. J., Zhang, H., Bandura, J. L., Heiberger, K. M., Glogauer, M., el-Hashemite, N., and Onda, H. (2002). A mouse model of TSC1 reveals sex-dependent lethality from liver hemangiomas, and up-regulation of p70S6 kinase activity in Tsc1 null cells. Hum. Mol. Genet. 11: 525-534.
30. Kyin, R., Hua, Y., Bayhis, M., Scheithauer, B., Kolson, D., Uhlmann, E., Gutmann, D. et al. (2001). Differential cellular expression of neurotrophins in cortical tubers of the tuberous sclerosis complex. Am. J. Pathol. 159: 1541-1554.
31. Mizuguchi, M., Ikeda, K., and Takashima, S. (2000). Simultaneous loss of hamartin and tuberin from the cerebrum, kidney and heart with tuberous sclerosis. Acta Neuropathol. (Berl) 99: 503-510.
32. Mukhopadhyay, N. K., Price, D. J., Kyriakis, J. M., Pelech, S., Sanghera, J., and Avruch, J. (1992). An array of insulin-activated, pro-line-directed serine/threonine protein kinases phosphorylate the p70 S6 kinase. J. Biol. Chem. 267: 3325-3335.
33. Nellist, M., van Slegtenhorst, M. A., Goedbloed, M., van den Ouwe-land, A. M., Halley, D. J., and van der Sluijs, P. (1999). Characterization of the cytosolic tuberin-hamartin complex. Tuberin is a cytosolic chaperone for hamartin. J. Biol. Chem. 274: 35647-35652.
34. Niida, Y., Stemmer-Rachamimov, A. O., Logrip, M., Tapon, D., Perez, R., Kwiatkowski, D. J., Sims, K. et al. (2001). Survey of somatic mutations in tuberous sclerosis complex (TSC) hamartomas suggests different genetic mechanisms for pathogenesis of TSC lesions. Am. J. Hum. Genet. 69: 493-503.
35. Onda, H., Lueck, A., Marks, P. W., Warren, H. B., and Kwiatkowski, D. J. (1999). Tsc2(3/3) mice develop tumors in multiple sites that express gelsolin and are influenced by genetic background. J. Clin. Invest. 104: 687-695.
36. Osborne, J. P., Fryer, A., and Webb, D. (1991). Epidemiology of tuberous sclerosis. Ann. N. Y. Acad. Sci. 615: 125-127.
37. Park, S. H., Pepkowitz, S. H., Kerfoot, C., De Rosa, M. J., Poukens, V., Wienecke, R., DeClue, J. E. et al. (1997). Tuberous sclerosis in a 20-week gestation fetus: Immunohistochemical study. Acta Neuropathol. (Berl) 94: 180-186.
38. Peterson, R. T., Desai, B. N., Hardwick, J. S., and Schreiber, S. L. (1999). Protein phosphatase 2A interacts with the 70-kDa S6 kinase and is activated by inhibition of FKBP 12-rapamycinassociated protein. Proc. Natl. Acad. Sci. USA 96: 4438 -4442.
39. Plank, T. L., Yeung, R. S., and Henske, E. P. (1998). Hamartin, the product of the tuberous sclerosis 1 (TSC1) gene, interacts with tuberin and appears to be localized to cytoplasmic vesicles. Cancer Res. 58: 4766-4770.
40. Potter, C. J., Huang, H., and Xu, T. (2001). Drosophila tsc1 functions with tsc2 to antagonize insulin signaling in regulating cell growth, cell proliferation, and organ size. Cell 105: 357-368.
41. Pullen, N., Dennis, P. B., Andjelkovic, M., Dufner, A., Kozma, S. C., Hemmings, B. A., and Thomas, G. (1998). Phosphorylation and activation of p70s6k by PDK1. Science 279: 707-710.
42. Richardson, E. J. (1991). Pathology of tuberous sclerosis. Neuropathologic aspects. Ann. N. Y. Acad. Sci. 615: 128-139.
43. Roach, E. S., Gomez, M. R., and Northrup, H. (1998). Tuberous sclerosis complex consensus conference: Revised clinical diagnostic criteria. J. Child Neurol. 13: 624-628.
44. Romanelli, A., Martin, K. A., Toker, A., and Blenis, J. (1999). p70 S6 kinase is regulated by protein kinase Czeta and participates in a phosphoinositide 3-kinase-regulated signalling complex. Mol. Cell. Biol. 19: 2921-2928.
45. Sampson, J. R., Scahill, S. J., Stephenson, J. B., Mann, L., and Connor, J. M. (1989). Genetic aspects of tuberous sclerosis in the west of Scotland. J. Med. Genet. 26: 28-31.
46. Sepp, T., Yates, J. R. W., and Green, A. J. (1996). Loss of heterozygosity in tuberous sclerosis hamartomas. J. Med. Genet. 33: 962-964.
47. Shepherd, C. W., Houser, O. W., and Gomez, M. R. (1995). MR findings in tuberous sclerosis complex and correlation with seizure development and mental impairment. Am. J. Neurorad. 16: 55.
48. Shimkets, R. A., Lowe, D. G., Tai, J. T., Sehl, P., Jin, H., Yang, R., Predki, P. F. et al. (1999). Gene expression analysis by transcript profiling coupled to a gene database query. Nat. Biotechnol. 17: 798-803.
49. Short, M. P., Richardson, E. J., Haines, J. L., and Kwiatkowski, D. J. (1995). Clinical neuropathological and genetic aspects of the tuberous sclerosis complex. Brain Pathol. 5: 173-179.
50. Tapon, N., Ito, N., Dickson, B. J., Treisman, J. E., and Hariharan, I. K. (2001). The drosophila tuberous sclerosis complex gene homologs restrict cell growth and cell proliferation. Cell 105: 345-355.
51. van Slegtenhorst, M., de Hoogt, R., Hermans, C., Nellist, M., Janssen, B., Verhoef, S., Lindhout, D. et al. (1997). Identification of the tuberous sclerosis gene TSC1 on chromosome 9q34. Science 277: 805-808.
52. van Slegtenhorst, M., Nellist, M., Nagelkerken, B., Cheadle, J., Snell, R., van den Ouweland, A., Reuser, A. et al. (1998). Interaction between hamartin and tuberin, the TSC1 and TSC2 gene products. Hum. Mol. Genet. 7: 1053-1058.
53. Westphal, R. S., Coffee, R. L., Jr., Marotta, A., Pelech, S. L., and Wadzinski, B. E. (1999). Identification of kinase-phosphatase signaling modules composed of p70 S6 kinase-protein phosphatase 2A (PP2A) and p21-activated kinase-PP2A. J. Biol. Chem. 274: 687-692.
54. White, R., Hua, Y., Scheithauer, B., Lynch, D. R., Henske, E. P., and Crino, P. B. (2001). Selective alterations in glutamate and GABA receptor subunit mRNA expression in dysplastic neurons and giant cells of cortical tubers. Ann. Neurol. 49: 67-78.
55. Yokogami, K., Wakisaka, S., Avruch, J., and Reeves, S. A. (2000). Serine phosphorylation and maximal activation of STAT3 during CNTF signaling is mediated by the rapamycin target mTOR. Curr. Biol. 10: 47-50.